TY - JOUR
T1 - Single-Base Resolution
T2 - Increasing the Specificity of the CRISPR-Cas System in Gene Editing
AU - Rabinowitz, Roy
AU - Offen, Daniel
N1 - Publisher Copyright:
© 2020 The American Society of Gene and Cell Therapy
PY - 2021/3/3
Y1 - 2021/3/3
N2 - The CRISPR-Cas system holds great promise in the treatment of diseases caused by genetic variations. The Cas protein, an RNA-guided programmable nuclease, generates a double-strand break at precise genomic loci. However, the use of the clustered regularly interspersed short palindromic repeats (CRISPR)-Cas system to distinguish between single-nucleotide variations is challenging. The promiscuity of the guide RNA (gRNA) and its mismatch tolerance make allele-specific targeting an elusive goal. This review presents a meta-analysis of previous studies reporting position-dependent mismatch tolerance within the gRNA. We also examine the conservativity of the seed sequence, a region within the gRNA with stringent sequence dependency, and propose the existence of a subregion within the seed sequence with a higher degree of specificity. In addition, we summarize the reports on high-fidelity Cas nucleases with improved specificity and compare the standard gRNA design methodology to the single-nucleotide polymorphism (SNP)-derived protospacer adjacent motif (PAM) approach, an alternative method for allele-specific targeting. The combination of the two methods may be advantageous in designing CRISPR-based therapeutics and diagnostics for heterozygous patients. In this review, Rabinowitz and Offen describe and compare the methods to improve the specificity of the CRISPR-Cas system, including high-fidelity synthetic enzymes, SNP-derived PAM and other methodologies. Furthermore, a meta-analysis of SpCas9 specificity profiles by several studies is presented to investigate the stringency of the gRNA seed sequence.
AB - The CRISPR-Cas system holds great promise in the treatment of diseases caused by genetic variations. The Cas protein, an RNA-guided programmable nuclease, generates a double-strand break at precise genomic loci. However, the use of the clustered regularly interspersed short palindromic repeats (CRISPR)-Cas system to distinguish between single-nucleotide variations is challenging. The promiscuity of the guide RNA (gRNA) and its mismatch tolerance make allele-specific targeting an elusive goal. This review presents a meta-analysis of previous studies reporting position-dependent mismatch tolerance within the gRNA. We also examine the conservativity of the seed sequence, a region within the gRNA with stringent sequence dependency, and propose the existence of a subregion within the seed sequence with a higher degree of specificity. In addition, we summarize the reports on high-fidelity Cas nucleases with improved specificity and compare the standard gRNA design methodology to the single-nucleotide polymorphism (SNP)-derived protospacer adjacent motif (PAM) approach, an alternative method for allele-specific targeting. The combination of the two methods may be advantageous in designing CRISPR-based therapeutics and diagnostics for heterozygous patients. In this review, Rabinowitz and Offen describe and compare the methods to improve the specificity of the CRISPR-Cas system, including high-fidelity synthetic enzymes, SNP-derived PAM and other methodologies. Furthermore, a meta-analysis of SpCas9 specificity profiles by several studies is presented to investigate the stringency of the gRNA seed sequence.
UR - http://www.scopus.com/inward/record.url?scp=85099522002&partnerID=8YFLogxK
U2 - 10.1016/j.ymthe.2020.11.009
DO - 10.1016/j.ymthe.2020.11.009
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 33248248
AN - SCOPUS:85099522002
SN - 1525-0016
VL - 29
SP - 937
EP - 948
JO - Molecular Therapy
JF - Molecular Therapy
IS - 3
ER -